(Q42947572)

English

Bevacizumab combined with two-weekly paclitaxel as first-line therapy for metastatic breast cancer

scientific article published on July 1, 2010

Statements

Bevacizumab combined with two-weekly paclitaxel as first-line therapy for metastatic breast cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit